{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T18:01:06Z","timestamp":1767895266425,"version":"3.49.0"},"reference-count":52,"publisher":"IOP Publishing","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/publishingsupport.iopscience.iop.org\/iop-standard\/v1"},{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/iopscience.iop.org\/info\/page\/text-and-data-mining"}],"funder":[{"name":"National Cancer Institute","award":["P30 CA006927"],"award-info":[{"award-number":["P30 CA006927"]}]}],"content-domain":{"domain":["iopscience.iop.org"],"crossmark-restriction":false},"short-container-title":["Biomed. Phys. Eng. Express"],"published-print":{"date-parts":[[2026,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Purpose.<\/jats:italic>\n                    Radiodynamic Therapy (RDT) is an emerging technique that enhances the therapeutic effects of radiation by using photosensitizers to amplify tumor cell damage while minimizing harm to normal tissues. This\n                    <jats:italic>in vitro<\/jats:italic>\n                    investigation compares the biocompatibility and sensitizing efficacy of two candidate photosensitizers, 5-aminolevulinic acid (5-ALA) and acridine orange (AO), in human breast adenocarcinoma (MCF7) and prostate adenocarcinoma (PC3) cell lines.\n                    <jats:italic>Materials and Methods.<\/jats:italic>\n                    MCF7 and PC3 cell lines were cultured and exposed to a range of 5-ALA and AO concentrations to assess biocompatibility using PrestoBlue viability assays. Based on these results, optimal concentrations were selected for irradiation experiments. Cells were then seeded in T-25 flasks and incubated with 5-ALA or AO prior to receiving 2 Gy or 4 Gy of megavoltage photon radiation (18 MV or 45 MV). Clonogenic assays were performed to determine the surviving fractions of the cells.\n                    <jats:italic>Results<\/jats:italic>\n                    . 5-ALA exhibited a broader biocompatibility profile than AO, remaining non-cytotoxic up to 100 \u03bcg ml\n                    <jats:sup>\u22121<\/jats:sup>\n                    . In contrast, AO showed cytotoxic effects above 1 \u03bcg ml\n                    <jats:sup>\u22121<\/jats:sup>\n                    . At 18 MV, limited radiosensitization was observed, except at higher 5-ALA concentrations. However, at 45 MV, both sensitizers significantly reduced cell survival, particularly at 4 Gy. The most pronounced effect was observed with 100 \u03bcg ml\n                    <jats:sup>\u22121<\/jats:sup>\n                    5-ALA, which consistently resulted in lower surviving fractions than AO across both cell lines. Each sensitizer demonstrated differing effectiveness depending on the cell line and photon energy used.\n                    <jats:italic>Conclusions<\/jats:italic>\n                    . Both 5-ALA and AO enhanced the cytotoxic effects of radiation, but 5-ALA demonstrated superior biocompatibility and more consistent radiosensitization across both cell lines. Notably, the effectiveness of both sensitizers increased with higher photon energy, reinforcing the importance of beam energy in RDT design. These results underscore the advantages of 5-ALA over AO and highlight the need to optimize both sensitizer selection and radiation energy in clinical applications.\n                  <\/jats:p>","DOI":"10.1088\/2057-1976\/ae2688","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T22:47:46Z","timestamp":1764715666000},"page":"015018","update-policy":"https:\/\/doi.org\/10.1088\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["An\n                    <i>in vitro<\/i>\n                    investigation of 5-aminolevulinic acid and acridine orange as sensitizers in radiodynamic therapy for prostate and breast cancer"],"prefix":"10.1088","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3608-3627","authenticated-orcid":false,"given":"Tristan K","family":"Gaddis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4654-4379","authenticated-orcid":true,"given":"Dusica","family":"Cvetkovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1229-7759","authenticated-orcid":true,"given":"Dae-Myoung","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5341-4827","authenticated-orcid":true,"given":"C-M Charlie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"266","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"bpexae2688bib1","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1269\/jrr.27.339","type":"journal-article","article-title":"mechanisms of photodynamic inactivation of acridine orange-sensitized transfer RNA: participation of singlet oxygen and base damage leading to inactivation","volume":"27","author":"Amagasa","year":"1986","journal-title":"J. Radiat. Res."},{"key":"bpexae2688bib2","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1089\/clm.1996.14.289","type":"journal-article","article-title":"Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): mechanisms and clinical results","volume":"14","author":"Kennedy","year":"1996","journal-title":"J. Clin. Laser Med. Surg."},{"key":"bpexae2688bib3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.30654\/MJCS.10024","type":"journal-article","article-title":"Investigation of the mechanisms of radio-dynamic therapy","volume":"5","author":"Zhang","year":"2020","journal-title":"Mathews J. Cancer Sci."},{"key":"bpexae2688bib4","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1118\/1.4888714","type":"journal-article","article-title":"SU-E-T-381: radio-dynamic therapy (RDT) for the treatment of late-stage cancers","volume":"41","author":"Ma","year":"2014","journal-title":"Med. Phys."},{"key":"bpexae2688bib5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2015.07.1882","type":"journal-article","article-title":"Radiation therapy combined with 5-aminolevulinic acid: a preliminary study with an In Vivo mouse model implanted with human PC-3 tumor cells","volume":"93","author":"Wang","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"bpexae2688bib6","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1038\/s41598-018-21152-z","type":"journal-article","article-title":"Verification of radiodynamic therapy by medical linear accelerator using a mouse melanoma tumor model","volume":"8","author":"Takahashi","year":"2018","journal-title":"Sci. Rep."},{"key":"bpexae2688bib7","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/ab9776","type":"journal-article","article-title":"Radiodynamic therapy using 15-MV radiation combined with 5-aminolevulinic acid and carbamide peroxide for prostate cancer In Vivo","volume":"65","author":"Panetta","year":"2020","journal-title":"Phys. Med. Biol."},{"key":"bpexae2688bib8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2530\/jslsm.jslsm-40_0056","type":"journal-article","article-title":"Photosensitizer and radio-dynamic therapy (RDT)","volume":"41","author":"Yamamoto","year":"2021","journal-title":"J. Jpn. Soc. Laser Surg. Med."},{"key":"bpexae2688bib9","first-page":"451","type":"journal-article","article-title":"Visible emission of clean liquids by action of \u03b3 radiation","volume":"2","author":"Cerenkov","year":"1934","journal-title":"Dokl. Akad. Nauk SSSR"},{"key":"bpexae2688bib10","doi-asserted-by":"publisher","first-page":"9446","DOI":"10.1021\/acs.jmedchem.0c00625","type":"journal-article","article-title":"Dual cherenkov radiation-induced near-infrared luminescence imaging and photodynamic therapy toward tumor resection","volume":"63","author":"Lioret","year":"2020","journal-title":"J. Med. Chem."},{"key":"bpexae2688bib11","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1118\/1.3592646","type":"journal-article","article-title":"Cerenkov emission induced by external beam radiation stimulates molecular fluorescence","volume":"38","author":"Axelsson","year":"2011","journal-title":"Med. Phys."},{"key":"bpexae2688bib12","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3390\/photonics9060390","type":"journal-article","article-title":"Cherenkov luminescence in tumor diagnosis and treatment: a review","volume":"9","author":"Wang","year":"2022","journal-title":"Photonics"},{"key":"bpexae2688bib13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1751-1097.1997.tb08549.x","type":"journal-article","article-title":"5-aminolevulinic acid-based photodynamic therapy: principles and experimental research","volume":"65","author":"Peng","year":"1997","journal-title":"Photochem. Photobiol."},{"key":"bpexae2688bib14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1054\/bjoc.2001.1875","type":"journal-article","article-title":"Photosensitization and mechanism of cytotoxicity induced by the use of ALA derivatives in photodynamic therapy","volume":"85","author":"Casas","year":"2001","journal-title":"Br. J. Cancer"},{"key":"bpexae2688bib15","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41416-019-0516-4","type":"journal-article","article-title":"In order for the light to shine so brightly, the darkness must be present\u2014why do cancers fluoresce with 5-aminolaevulinic acid?","volume":"121","author":"McNicholas","year":"2019","journal-title":"Br. J. Cancer"},{"key":"bpexae2688bib16","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.3892\/or.2012.1699","type":"journal-article","article-title":"Radiosensitizing effect of 5-aminolevulinic acid-induced protoporphyrin IX in Glioma cells In Vitro","volume":"27","author":"Yamamoto","year":"2012","journal-title":"Oncol. Rep."},{"key":"bpexae2688bib17","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.3390\/pharmaceutics16091135","type":"journal-article","article-title":"Treating deep-seated tumors with radiodynamic therapy: progress and perspectives","volume":"16","author":"Zhu","year":"2024","journal-title":"Pharmaceutics"},{"key":"bpexae2688bib18","doi-asserted-by":"publisher","first-page":"18002","DOI":"10.1117\/1.3302811","type":"journal-article","article-title":"Preferential accumulation of 5-aminolevulinic acid-induced protoporphyrin IX in breast cancer: a comprehensive study on six breast cell lines with varying phenotypes","volume":"15","author":"Millon","year":"2010","journal-title":"J. Biomed. Opt."},{"key":"bpexae2688bib19","doi-asserted-by":"publisher","first-page":"e50082","DOI":"10.1371\/journal.pone.0050082","type":"journal-article","article-title":"Mitochondrial localization of ABC transporter ABCG2 and its function in 5-aminolevulinic acid-mediated protoporphyrin IX accumulation","volume":"7","author":"Kobuchi","year":"2012","journal-title":"PLoS One"},{"key":"bpexae2688bib20","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3390\/ph14030229","type":"journal-article","article-title":"Systematic review and meta-analysis of in vitro anti-human cancer experiments investigating the use of 5-aminolevulinic acid (5-ALA) for photodynamic therapy","volume":"14","author":"Shinoda","year":"2021","journal-title":"Pharmaceuticals"},{"key":"bpexae2688bib21","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1186\/2193-1801-2-602","type":"journal-article","article-title":"5-Aminolevulinic acid enhances cancer radiotherapy in a mouse tumor model","volume":"2","author":"Takahashi","year":"2013","journal-title":"Springerplus"},{"key":"bpexae2688bib22","doi-asserted-by":"publisher","first-page":"5596","DOI":"10.3390\/ijms22115596","type":"journal-article","article-title":"Antitumor effects of 5-aminolevulinic acid on human malignant glioblastoma cells","volume":"22","author":"Jalili-Nik","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"bpexae2688bib23","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3892\/etm.2023.12059","type":"journal-article","article-title":"5-aminiolevulinic acid induces a radiodynamic effect with enhanced delayed reactive oxygen species production under hypoxic conditions in lymphoma cells: an In Vitro study","volume":"26","author":"Suzuki","year":"2023","journal-title":"Exp. Ther. Med."},{"key":"bpexae2688bib24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00066-025-02420-0","type":"journal-article","article-title":"5-Aminolevulinic acid as an emerging radiosensitizer for radiodynamic therapy in solid tumors: a systematic review of available data and clinical potential","volume":"201","author":"Pepper","year":"2025","journal-title":"Strahlentherapie und Onkologie"},{"key":"bpexae2688bib25","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3892\/ijmm.2016.2841","type":"journal-article","article-title":"5-aminolevulinic acid enhances mitochondrial stress upon ionizing irradiation exposure and increases delayed production of reactive oxygen species and cell death in glioma cells","volume":"39","author":"Ueta","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"bpexae2688bib26","doi-asserted-by":"publisher","DOI":"10.1088\/2057-1976\/ac9b5c","type":"journal-article","article-title":"Therapeutic effects of in-vivo radiodynamic therapy (RDT) for lung cancer treatment: a combination of 15MV photons and 5-aminolevulinic acid (5-ALA)","volume":"8","author":"Yang","year":"2022","journal-title":"Biomed. Phys. Eng. Express"},{"key":"bpexae2688bib27","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1699-0463.1977.tb01970.x","type":"journal-article","article-title":"Differential staining of bacteria in clinical specimens using acridine orange buffered at low pH","volume":"85","author":"Kronvall","year":"1977","journal-title":"Acta Pathol. Microbiol. Scand. B"},{"key":"bpexae2688bib28","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1128\/jcm.11.3.281-285.1980","type":"journal-article","article-title":"Evaluation of acridine orange stain for detection of microorganisms in blood cultures","volume":"11","author":"McCarthy","year":"1980","journal-title":"J. Clin. Microbiol."},{"key":"bpexae2688bib29","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/bjc.1969.72","type":"journal-article","article-title":"Tumorigenicity of acridine orange","volume":"23","author":"Van Duuren","year":"1969","journal-title":"Br. J. Cancer"},{"key":"bpexae2688bib30","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.cellbi.2006.06.017","type":"journal-article","article-title":"Acridine orange accumulation in acid organelles of normal and vacuolated frog skeletal muscle fibres","volume":"30","author":"Krolenko","year":"2006","journal-title":"Cell Biol. Int."},{"key":"bpexae2688bib31","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.3390\/biomedicines10081904","type":"journal-article","article-title":"Radiodynamic Therapy with acridine orange is an effective treatment for bone metastases","volume":"10","author":"Di Pompo","year":"2022","journal-title":"Biomedicines"},{"key":"bpexae2688bib32","first-page":"205","type":"journal-article","article-title":"Acridine orange could be an innovative anticancer agent under photon energy","volume":"21","author":"Kusuzaki","year":"2007","journal-title":"In Vivo"},{"key":"bpexae2688bib33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13904-0","type":"journal-article","article-title":"Acridine orange exhibits photodamage in human bladder cancer cells under blue light exposure","volume":"7","author":"Lin","year":"2017","journal-title":"Sci. Rep."},{"key":"bpexae2688bib34","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.2174\/138161212799504812","type":"journal-article","article-title":"Translational research of photodynamic therapy with acridine orange which targets cancer acidity","volume":"18","author":"Kusuzaki","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"bpexae2688bib35","doi-asserted-by":"publisher","first-page":"5828","DOI":"10.1158\/0008-5472.CAN-06-0139","type":"journal-article","article-title":"Sulforaphane causes autophagy to inhibit release of cytochrome C and apoptosis in human prostate cancer cells","volume":"66","author":"Herman-Antosiewicz","year":"2006","journal-title":"Cancer Res."},{"key":"bpexae2688bib36","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s00432-019-02898-z","type":"journal-article","article-title":"TRPM2 mediates distruption of autophagy machinery and correlates with the grade level in prostate cancer","volume":"145","author":"Tektemur","year":"2019","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"key":"bpexae2688bib37","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1016\/j.nano.2016.05.008","type":"journal-article","article-title":"The ligand (s) anchored lipobrid nanoconstruct mediated delivery of methotrexate: an effective approach in breast cancer therapeutics","volume":"12","author":"Garg","year":"2016","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"bpexae2688bib38","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.2147\/IJN.S106418","type":"journal-article","article-title":"The cellular uptake mechanism, intracellular transportation, and exocytosis of polyamidoamine dendrimers in multidrug-resistant breast cancer cells","volume":"2016:11","author":"Zhang","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"bpexae2688bib39","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1159\/000048251","type":"journal-article","article-title":"Acridine orange excited by low-dose radiation has a strong cytocidal effect on mouse osteosarcoma","volume":"62","author":"Hashiguchi","year":"2002","journal-title":"Oncology"},{"key":"bpexae2688bib40","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1302\/2046-3758.1110.BJR-2022-0105.R2","type":"journal-article","article-title":"Radiodynamic therapy with acridine orange local administration as a new treatment option for primary and secondary bone tumours","volume":"11","author":"Matsuyama","year":"2022","journal-title":"Bone Joint Res."},{"key":"bpexae2688bib41","doi-asserted-by":"publisher","first-page":"481","DOI":"10.21873\/anticanres.12248","type":"journal-article","article-title":"Clinical trial of radiotherapy after intravenous injection of acridine orange for patients with cancer","volume":"38","author":"Kusuzaki","year":"2018","journal-title":"Anticancer Res."},{"key":"bpexae2688bib42","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.bbrc.2006.05.158","type":"journal-article","article-title":"Intrinsic radiation resistance in human chondrosarcoma cells","volume":"346","author":"Moussavi-Harami","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"bpexae2688bib43","doi-asserted-by":"publisher","first-page":"4244","DOI":"10.3390\/cancers14174244","type":"journal-article","article-title":"An orthotopic model of glioblastoma is resistant to radiodynamic therapy with 5-aminolevulinic acid","volume":"14","author":"Dupin","year":"2022","journal-title":"Cancers"},{"key":"bpexae2688bib44","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1349-7006.2000.tb00964.x","type":"journal-article","article-title":"Photodynamic inactivation with acridine orange on a multidrug-resistant mouse osteosarcoma cell line","volume":"91","author":"Kusuzaki","year":"2000","journal-title":"Jpn. J. Cancer Res."},{"key":"bpexae2688bib45","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s12951-022-01537-z","type":"journal-article","article-title":"Radiodynamic therapy with CsI(Na)@MgO nanoparticles and 5-aminolevulinic acid","volume":"20","author":"Jiang","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"bpexae2688bib46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphotobiol.2019.111586","type":"journal-article","article-title":"Metronomic photodynamic therapy with 5-aminolevulinic acid induces apoptosis and autophagy in human SW837 colorectal cancer cells","volume":"198","author":"Shi","year":"2019","journal-title":"J. Photochem. Photobiol., B"},{"key":"bpexae2688bib47","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0165-1110(91)90006-H","type":"journal-article","article-title":"The genetic toxicology of acridines","volume":"258","author":"Ferguson","year":"1991","journal-title":"Mutation Research\/Reviews in Genetic Toxicology"},{"key":"bpexae2688bib48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0165-1218(84)90105-8","type":"journal-article","article-title":"Biological effects of dyes on bacteria VI. Mutation induction by acridine orange and methylene blue in the dark with special reference to Escherichia coli WP6 (polA1)","volume":"137","author":"Webb","year":"1984","journal-title":"Mutation Research\/Genetic Toxicology"},{"key":"bpexae2688bib49","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1159\/000354479","type":"journal-article","article-title":"DNA damage and cell cycle arrest induced by protoporphyrin IX in sarcoma 180 cells","volume":"32","author":"Li","year":"2013","journal-title":"Cell. Physiol. Biochem."},{"key":"bpexae2688bib50","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/genes10010025","type":"journal-article","article-title":"Targeting DNA double-strand break repair pathways to improve radiotherapy response","volume":"10","author":"Toulany","year":"2019","journal-title":"Genes"},{"key":"bpexae2688bib51","doi-asserted-by":"publisher","first-page":"40514","DOI":"10.1039\/C5RA04013B","type":"journal-article","article-title":"BSA capped Au nanoparticle as an efficient sensitizer for glioblastoma tumor radiation therapy","volume":"5","author":"Chen","year":"2015","journal-title":"RSC Adv."},{"key":"bpexae2688bib52","doi-asserted-by":"publisher","first-page":"9509","DOI":"10.1039\/D4RA00208C","type":"journal-article","article-title":"Increase of OH radical yields due to the decomposition of hydrogen peroxide by gold nanoparticles under X-ray irradiation","volume":"14","author":"Okazaki","year":"2024","journal-title":"RSC Adv."}],"container-title":["Biomedical Physics &amp; Engineering Express"],"original-title":[],"link":[{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/2057-1976\/ae2688","content-type":"text\/html","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/2057-1976\/ae2688\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/2057-1976\/ae2688","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/2057-1976\/ae2688\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/2057-1976\/ae2688\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/2057-1976\/ae2688\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/2057-1976\/ae2688\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"similarity-checking"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/2057-1976\/ae2688\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T12:21:09Z","timestamp":1767874869000},"score":1,"resource":{"primary":{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/2057-1976\/ae2688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12,11]]},"published-print":{"date-parts":[[2026,2,1]]}},"URL":"https:\/\/doi.org\/10.1088\/2057-1976\/ae2688","relation":{},"ISSN":["2057-1976"],"issn-type":[{"value":"2057-1976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"An\n                      in vitro\n                      investigation of 5-aminolevulinic acid and acridine orange as sensitizers in radiodynamic therapy for prostate and breast cancer","name":"article_title","label":"Article Title"},{"value":"Biomedical Physics & Engineering Express","name":"journal_title","label":"Journal Title"},{"value":"paper","name":"article_type","label":"Article Type"},{"value":"\u00a9 2025 IOP Publishing Ltd. All rights, including for text and data mining, AI training, and similar technologies, are reserved.","name":"copyright_information","label":"Copyright Information"},{"value":"2025-09-03","name":"date_received","label":"Date Received","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2025-12-02","name":"date_accepted","label":"Date Accepted","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2025-12-11","name":"date_epub","label":"Online publication date","group":{"name":"publication_dates","label":"Publication dates"}}]}}